Post by Orange Biomed

😀 What an incredible week at #ADA2026 in New Orleans. Thank you to everyone who visited the Orange Biomed team throughout the conference, attended our Late Breaking Poster presentation, and shared thoughtful discussions around the future of diabetes technology and accessible A1c monitoring. We were especially excited to present our research, “Improving the Reproducibility of Red Blood Cell Transit Velocity Distributions for HbA1c Estimation Using a Microfluidic Sensor,” and grateful for the strong interest, insightful feedback, and meaningful conversations that followed throughout the meeting. It was a pleasure connecting with so many clinicians, researchers, diabetes advocates, and industry leaders during ADA 2026, including Jaime Almandoz, MD, MBA, FTOS, Ginger Vieira, Tara Mayo, Justin Eastzer, Dr. Tomas W. Martens(MD), Karen J., Prof. Mikito Yasuzawa (Tokushima University), Robert Gabbay MD, PhD, Cristina Rondinone , Soumitra Ghosh, Ph.D., Steve Edelman, Sean Oser, Dr. Eugene E. Wright, Jr(MD) and many others. We truly appreciated the opportunity to exchange ideas with passionate members of the global diabetes community and discuss the future of accessible diabetes monitoring and microfluidic based innovation. Looking forward to continuing these conversations beyond ADA 2026 and sharing more updates soon. #ADA #AmericanDiabetesAssociation #ADA2026 #ADAScientificSessions #Diabetes #A1C #DiabetesTechnology #Microfluidics #DigitalHealth #DiabetesManagement #OrangeBiomed